help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Published ahead of print on June 19, 2003, doi:10.1165/rcmb.2002-0046OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2002-0046OCv1
29/6/669    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujita, M.
Right arrow Articles by Mason, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujita, M.
Right arrow Articles by Mason, R. J.
American Journal of Respiratory Cell and Molecular Biology. Vol. 29, pp. 669-676, 2003
© 2003 American Thoracic Society
DOI: 10.1165/rcmb.2002-0046OC

Overexpression of Tumor Necrosis Factor-{alpha} Diminishes Pulmonary Fibrosis Induced by Bleomycin or Transforming Growth Factor-ß

Masaki Fujita, John M. Shannon, Osamu Morikawa, Jack Gauldie, Nobuyuki Hara and Robert J. Mason

Department of Medicine, National Jewish Medical and Research Center, Denver, Colorado; Department of Pathology, University of McMaster, Hamilton, Ontario, Canada; and Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

Address correspondence to: Robert J. Mason, M.D., Department of Medicine, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, CO 80206. E-mail: masonb{at}njc.org

Tumor necrosis factor-{alpha} (TNF-{alpha}) is thought to be important in the development of pulmonary fibrosis. However, surfactant protein-C/TNF-{alpha} transgenic mice do not spontaneously develop pulmonary fibrosis but instead develop alveolar enlargement and loss of elastic recoil. We hypothesized that overexpression of TNF-{alpha} in the lung requires an additional insult to produce fibrosis. In this study we evaluated whether TNF-{alpha} overexpression altered the development of pulmonary fibrosis due to bleomycin or transforming growth factor-ß (TGF-ß). Either 0.2 U bleomycin or saline was administered into left lung of TNF-{alpha} transgenic mice and their transgene-negative littermates. To overexpress TGF-ß, an adenovirus vector containing either active TGF-ß (AdTGF-ß) or LacZ was administered at a dose of 3 x 108 plaque-forming units per mouse. Fibrosis was assessed histologically and by measurement of hydroxyproline. TNF-{alpha} transgenic mice tolerated bleomycin or AdTGF-ß, whereas the transgene-negative littermates demonstrated severe pulmonary fibrosis after either agent. An increase in prostaglandin E2 and downregulation of TNF receptor I expression were observed in the TNF-{alpha} transgenic mice. In addition, recombinant human TNF-{alpha} attenuated bleomycin-induced pulmonary fibrosis. TNF-{alpha} has a complex role in the development of pulmonary fibrosis. Endogenous TNF-{alpha} may be important in the development of fibrosis as indicated in other reports, but overexpression of TNF-{alpha} or exogenous TNF-{alpha} limits pulmonary fibrosis in mice.

Abbreviations: LacZ adenovirus, AdLacZ • adenovirus vector of TGF-ß, AdTGF-ß • bronchoalveolar lavage, BAL • bleomycin, BLM • enzyme-linked immunosorbent assay, ELISA • idiopathic pulmonary fibrosis, IPF • matrix metalloproteinase, MMP • prostaglandin E2, PGE2 • recombinant tumor necrosis factor-{alpha}, rTNF-{alpha} • ribonuclease protection assay, RPA • surfactant protein C, SP-C • transforming growth factor-ß, TGF-ß • tumor necrosis factor-{alpha}, TNF-{alpha} • TNF receptor, TNFR




This article has been cited by other articles:


Home page
 Am. J. Respir. Cell Mol. Bio.Home page
J. F. Alcorn, J. van der Velden, A. L. Brown, B. McElhinney, C. G. Irvin, and Y. M. W. Janssen-Heininger
c-Jun N-Terminal Kinase 1 Is Required for the Development of Pulmonary Fibrosis
Am. J. Respir. Cell Mol. Biol., April 1, 2009; 40(4): 422 - 432.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
T J Williams and J W Wilson
Challenges in pulmonary fibrosis: 7 {middle dot} Novel therapies and lung transplantation
Thorax, March 1, 2008; 63(3): 277 - 284.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
B. B. Moore and C. M. Hogaboam
Murine models of pulmonary fibrosis
Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L152 - L160.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
N. Pottier, C. Chupin, V. Defamie, B. Cardinaud, R. Sutherland, G. Rios, F. Gauthier, P. J. Wolters, Y. Berthiaume, P. Barbry, et al.
Relationships between Early Inflammatory Response to Bleomycin and Sensitivity to Lung Fibrosis: A Role for Dipeptidyl-Peptidase I and Tissue Inhibitor of Metalloproteinase-3?
Am. J. Respir. Crit. Care Med., December 1, 2007; 176(11): 1098 - 1107.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
K. Pochetuhen, I. G. Luzina, V. Lockatell, J. Choi, N. W. Todd, and S. P. Atamas
Complex Regulation of Pulmonary Inflammation and Fibrosis by CCL18
Am. J. Pathol., August 1, 2007; 171(2): 428 - 437.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S. Fujita, S. Saika, W. W.-Y. Kao, K. Fujita, T. Miyamoto, K. Ikeda, Y. Nakajima, and Y. Ohnishi
Endogenous TNF{alpha} Suppression of Neovascularization in Corneal Stroma in Mice
Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 3051 - 3055.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
A. M. Pastva, J. R. Wright, and K. L. Williams
Immunomodulatory Roles of Surfactant Proteins A and D: Implications in Lung Disease
Proceedings of the ATS, July 1, 2007; 4(3): 252 - 257.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
K. Chen, Y. Wei, G. C. Sharp, and H. Braley-Mullen
Decreasing TNF-{alpha} results in less fibrosis and earlier resolution of granulomatous experimental autoimmune thyroiditis
J. Leukoc. Biol., January 1, 2007; 81(1): 306 - 314.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
S. Saika, K. Ikeda, O. Yamanaka, K. C. Flanders, Y. Okada, T. Miyamoto, A. Kitano, A. Ooshima, Y. Nakajima, Y. Ohnishi, et al.
Loss of Tumor Necrosis Factor {alpha} Potentiates Transforming Growth Factor {beta}-mediated Pathogenic Tissue Response during Wound Healing
Am. J. Pathol., June 1, 2006; 168(6): 1848 - 1860.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
S. K. Frankel, G. P. Cosgrove, S.-I. Cha, C. D. Cool, M. W. Wynes, B. L. Edelman, K. K. Brown, and D. W. H. Riches
TNF-{alpha} Sensitizes Normal and Fibrotic Human Lung Fibroblasts to Fas-Induced Apoptosis
Am. J. Respir. Cell Mol. Biol., March 1, 2006; 34(3): 293 - 304.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
M. Fujita, Q. Ye, H. Ouchi, E. Harada, I. Inoshima, K. Kuwano, and Y. Nakanishi
Doxycycline Attenuated Pulmonary Fibrosis Induced by Bleomycin in Mice
Antimicrob. Agents Chemother., February 1, 2006; 50(2): 739 - 743.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
L. K. A. Lundblad, J. Thompson-Figueroa, T. Leclair, M. J. Sullivan, M. E. Poynter, C. G. Irvin, and J. H. T. Bates
Tumor Necrosis Factor-{alpha} Overexpression in Lung Disease: A Single Cause behind a Complex Phenotype
Am. J. Respir. Crit. Care Med., June 15, 2005; 171(12): 1363 - 1370.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
D. E. Sullivan, M. Ferris, D. Pociask, and A. R. Brody
Tumor Necrosis Factor-{alpha} Induces Transforming Growth Factor-{beta}1 Expression in Lung Fibroblasts Through the Extracellular Signal-Regulated Kinase Pathway
Am. J. Respir. Cell Mol. Biol., April 1, 2005; 32(4): 342 - 349.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2003 American Thoracic Society. 		  CCM abstracts